Carla is a scientist with over 20 years’ experience in conducting health outcomes research studies, including instrument development and psychometric evaluation, design, and implementation of Clinical Outcomes Assessment (COA) endpoint strategies for clinical programs, quantitative and qualitative COA studies, and literature reviews. This work has been performed in a wide variety of disease areas, including skin diseases, pain, endocrinology, musculoskeletal disorders, respiratory diseases, oncology, rare diseases, and paediatric diseases. Carla also has experience implementing and conducting exit and embedded clinical trial interview studies, using mixed method research design and longitudinal qualitative research approach. She is co-chair of the International Society for Quality of Life Research (ISOQOL) Mixed Method Research Special Interest Group, and currently leads an ISOQOL program that aims to promote the use of longitudinal qualitative research in health outcomes research and defining best-practice methodologies.
Prior to joining Evidera, Carla worked at Mapi Patient Centered Outcomes Research (formerly Mapi Values) for 17 years. As associate research director, she was responsible for designing and conducting patient-centered outcomes studies. She has collaborated with patient advocacy groups, conducted studies using social media, and managed the development and validation of tools and screeners for use in clinical trials and clinical practice. She has authored several manuscripts that have been published in peer-reviewed journals and has delivered presentations at international scientific conferences, including ISPOR, ISOQOL, and the World Orphan Drug Congress.
Carla holds a master’s degree in biology and physiology from the University of Lyon in France and a European Market Access University Diploma (EMAUD) from the Aix-Marseille University in France. She is fluent in French, Portuguese, and English.